TFX benefits from a diversified product portfolio in the fourth quarter of 2024, with strength in the Surgical and ...

Learn more about whether LeMaitre Vascular, Inc. or Teleflex Incorporated is a better investment based on AAII's A+ Investor ...

Shares of medical technology company Teleflex (NYSE:TFX) fell 22.9% in the morning session after the company reported ...

Teleflex vascular access (24% of sales) is a no-moat business, in our view. While Teleflex leads the market for central venous catheters, or CVC, tubes that are connected to veins and used to deliver ...

Teleflex faced multiple downgrades from investment banks on Friday after the company reported disappointing fourth-quarter earnings, weak 2025 guidance, and announced plans to split into two publicly ...

Teleflex Inc. closed 44.33% below its 52-week high of $249.91, which the company reached on September 27th.

After the split, Teleflex would focus on devices for bloodstream and heart procedures, along with medical imaging, while ...

Good morning, ladies and gentlemen, and welcome to the Teleflex Fourth Quarter 2024 Earnings Conference Call. At this time all participants have been placed in a listen-only mode. At the end of the ...

Raymond James downgraded Teleflex (TFX) to Market Perform from Outperform without a price target The firm likes the company’s active portfolio ...

Teleflex's business units, including urology and acute care will come under NewCo, with interventional and surgical under ...

Piper Sandler analyst Matt O’Brien downgraded Teleflex (TFX) to Neutral from Overweight with a price target of $140, down from $255. The ...

Principal Financial Group Inc. reduced its stake in Teleflex Incorporated (NYSE:TFX – Free Report) by 13.1% during the fourth ...